127 related articles for article (PubMed ID: 35073481)
21. Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAF
Wang Z; Sun K; Jing C; Cao H; Ma R; Wu J
J Clin Lab Anal; 2019 Jul; 33(6):e22902. PubMed ID: 31021028
[TBL] [Abstract][Full Text] [Related]
22. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.
Reid AL; Freeman JB; Millward M; Ziman M; Gray ES
Clin Biochem; 2015 Oct; 48(15):999-1002. PubMed ID: 25523300
[TBL] [Abstract][Full Text] [Related]
23. Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers.
Möhrmann L; Huang HJ; Hong DS; Tsimberidou AM; Fu S; Piha-Paul SA; Subbiah V; Karp DD; Naing A; Krug A; Enderle D; Priewasser T; Noerholm M; Eitan E; Coticchia C; Stoll G; Jordan LM; Eng C; Kopetz ES; Skog J; Meric-Bernstam F; Janku F
Clin Cancer Res; 2018 Jan; 24(1):181-188. PubMed ID: 29051321
[No Abstract] [Full Text] [Related]
24. Quantitative analysis of the BRAF
Ashida A; Sakaizawa K; Mikoshiba A; Uhara H; Okuyama R
Int J Clin Oncol; 2016 Oct; 21(5):981-988. PubMed ID: 27041702
[TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay.
Vallée A; Denis-Musquer M; Herbreteau G; Théoleyre S; Bossard C; Denis MG
PLoS One; 2019; 14(8):e0221123. PubMed ID: 31415669
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.
Ibrahem S; Seth R; O'Sullivan B; Fadhil W; Taniere P; Ilyas M
Int J Exp Pathol; 2010 Dec; 91(6):500-5. PubMed ID: 21199003
[TBL] [Abstract][Full Text] [Related]
27. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.
Taly V; Pekin D; Benhaim L; Kotsopoulos SK; Le Corre D; Li X; Atochin I; Link DR; Griffiths AD; Pallier K; Blons H; Bouché O; Landi B; Hutchison JB; Laurent-Puig P
Clin Chem; 2013 Dec; 59(12):1722-31. PubMed ID: 23938455
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
[TBL] [Abstract][Full Text] [Related]
29. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
[TBL] [Abstract][Full Text] [Related]
30. Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.
Ihle MA; Fassunke J; König K; Grünewald I; Schlaak M; Kreuzberg N; Tietze L; Schildhaus HU; Büttner R; Merkelbach-Bruse S
BMC Cancer; 2014 Jan; 14():13. PubMed ID: 24410877
[TBL] [Abstract][Full Text] [Related]
31. BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.
Roma C; Rachiglio AM; Pasquale R; Fenizia F; Iannaccone A; Tatangelo F; Antinolfi G; Parrella P; Graziano P; Sabatino L; Colantuoni V; Botti G; Maiello E; Normanno N
Cancer Biol Ther; 2016 Aug; 17(8):840-8. PubMed ID: 27261210
[TBL] [Abstract][Full Text] [Related]
32. ACB-PCR Quantification of Low-Frequency Hotspot Cancer-Driver Mutations.
Myers MB; McKim KL; Wang Y; Banda M; Parsons BL
Methods Mol Biol; 2020; 2102():395-417. PubMed ID: 31989569
[TBL] [Abstract][Full Text] [Related]
33. Current and Emerging Applications of Droplet Digital PCR in Oncology.
Olmedillas-López S; García-Arranz M; García-Olmo D
Mol Diagn Ther; 2017 Oct; 21(5):493-510. PubMed ID: 28477149
[TBL] [Abstract][Full Text] [Related]
34. Nuclease-Assisted Minor Allele Enrichment Using Overlapping Probes-Assisted Amplification-Refractory Mutation System: An Approach for the Improvement of Amplification-Refractory Mutation System-Polymerase Chain Reaction Specificity in Liquid Biopsies.
Markou A; Tzanikou E; Ladas I; Makrigiorgos GM; Lianidou E
Anal Chem; 2019 Oct; 91(20):13105-13111. PubMed ID: 31538770
[TBL] [Abstract][Full Text] [Related]
35. 454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.
Altimari A; de Biase D; De Maglio G; Gruppioni E; Capizzi E; Degiovanni A; D'Errico A; Pession A; Pizzolitto S; Fiorentino M; Tallini G
Onco Targets Ther; 2013; 6():1057-64. PubMed ID: 23950653
[TBL] [Abstract][Full Text] [Related]
36. KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells.
Lewandowska MA; Jóźwicki W; Żurawski B
Mol Diagn Ther; 2013 Jun; 17(3):193-203. PubMed ID: 23606169
[TBL] [Abstract][Full Text] [Related]
37. Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation.
Morandi L; de Biase D; Visani M; Cesari V; De Maglio G; Pizzolitto S; Pession A; Tallini G
PLoS One; 2012; 7(4):e36084. PubMed ID: 22558339
[TBL] [Abstract][Full Text] [Related]
38. Molecular platforms utilized to detect BRAF V600E mutation in melanoma.
Curry JL; Torres-Cabala CA; Tetzlaff MT; Bowman C; Prieto VG
Semin Cutan Med Surg; 2012 Dec; 31(4):267-73. PubMed ID: 23174497
[TBL] [Abstract][Full Text] [Related]
39. Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients.
Kaneko A; Kanemaru H; Kajihara I; Mijiddorj T; Miyauchi H; Kuriyama H; Kimura T; Sawamura S; Makino K; Miyashita A; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
J Dermatol Sci; 2021 Jun; 102(3):158-166. PubMed ID: 34049769
[TBL] [Abstract][Full Text] [Related]
40. Optimized allele-specific real-time PCR assays for the detection of common mutations in KRAS and BRAF.
Lang AH; Drexel H; Geller-Rhomberg S; Stark N; Winder T; Geiger K; Muendlein A
J Mol Diagn; 2011 Jan; 13(1):23-8. PubMed ID: 21227391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
